616454 Sigma-AldrichTGF-β RI Kinase Inhibitor IV - CAS 909910-43-6 - Calbiochem
TGF-β RI Kinase Inhibitor IV, CAS 909910-43-6, is a cell-permeable, selective inhibitor of ALK-4/5/7-mediated signaling (IC₅₀ = 45, 12, and 7.5 nM, respectively).
More>> TGF-β RI Kinase Inhibitor IV, CAS 909910-43-6, is a cell-permeable, selective inhibitor of ALK-4/5/7-mediated signaling (IC₅₀ = 45, 12, and 7.5 nM, respectively). Less<<Synonyms: Transforming Growth Factor-β Type I Receptor Kinase Inhibitor IV, 3-(6-Methylpyridin-2-yl)-4-(4-quinolyl)-1-phenylthiocarbamoyl-1H-pyrazole, A-83-01, ALK5 Inhibitor IV
Recommended Products
개요
| Replacement Information |
|---|
주요 사양표
| CAS # | Empirical Formula |
|---|---|
| 909910-43-6 | C₂₅H₁₉N₅S |
가격 및 재고여부
| 카탈로그 번호 | 재고 정보 | 패킹 | 포장 단위 | 가격(VAT 별도) | 수량 | |
|---|---|---|---|---|---|---|
| 616454-2MGCN |
|
Plastic ampoule | 2 mg |
|
— |
| References | |
|---|---|
| References | Tojo, M., et al. 2005. Cancer Sci. 96, 791. |
| Product Information | |
|---|---|
| CAS number | 909910-43-6 |
| ATP Competitive | N |
| Form | Pale yellow solid |
| Hill Formula | C₂₅H₁₉N₅S |
| Chemical formula | C₂₅H₁₉N₅S |
| Reversible | N |
| Structure formula Image | |
| Quality Level | MQ200 |
| Applications |
|---|
| Physicochemical Information | |
|---|---|
| Cell permeable | Y |
| Dimensions |
|---|
| Materials Information |
|---|
| Toxicological Information |
|---|
| Safety Information according to GHS |
|---|
| Safety Information |
|---|
| Product Usage Statements |
|---|
| Packaging Information | |
|---|---|
| Packaged under inert gas | Packaged under inert gas |
| Transport Information |
|---|
| Supplemental Information |
|---|
| Specifications |
|---|
| Global Trade Item Number | |
|---|---|
| 카탈로그 번호 | GTIN |
| 616454-2MGCN | 04055977185867 |
Documentation
TGF-β RI Kinase Inhibitor IV - CAS 909910-43-6 - Calbiochem MSDS
| 타이틀 |
|---|
TGF-β RI Kinase Inhibitor IV - CAS 909910-43-6 - Calbiochem Certificates of Analysis
| Title | Lot Number |
|---|---|
| 616454 |
References
| 참고문헌 보기 |
|---|
| Tojo, M., et al. 2005. Cancer Sci. 96, 791. |



